Latest Breaking News On - Head of research development at lundbeck - Page 1 : comparemela.com

Novel LAI antipsychotic approved in EU

Novel LAI antipsychotic approved in EU
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Johan luthmanOtsuka europePeter gillbergAbilify maintenaHead of medical affairs at otsuka europeEuropean medicines agencyHead of research development at lundbeckEuropean commissionOtsuka pharmaceutical europe ltdVice presidentMedical affairsExecutive vice president

Abilify Maintena® 960 mg (aripiprazole) approved in the EU as the first once-every-two-months long-acting injectable for the maintenance treatment of

Aripiprazole’s new long-acting injectable (LAI) formulation enables continuous exposure to medication for two months1.Windsor, United Kingdom/Valby, Denmark, 27 March, 2024 – Otsuka Pharmaceutical Europe Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announced that the European Commission (EC) has ap.

Abilify maintenaPeter gillbergOtsuka europeJohan luthmanEuropean commissionOtsuka pharmaceutical company ltdOtsuka holdings co ltdHead of medical affairs at otsuka europeEuropean unionOtsuka pharmaceutical europe ltdHead of research development at lundbeckOtsuka pharmaceutical europeExecutive vice presidentVice presidentMedical affairsPharmaceutical europe

Long-term benefits of Vyepti® confirmed by new data presented at the annual meeting of the American Headache Society

Long-term benefits of Vyepti® confirmed by new data presented at the annual meeting of the American Headache SocietyAn extension phase of the DELIVER study with Vyepti® (eptinezumab) demonstrated long-lasting migraine preventive effects with treatment for up to 18 months, reducing both frequency and severity.

United statesJohan luthmanThomas mikkel mortensenPalle holm olesenEuropean medicines agencyDrug administrationHarris poll migraine report cardAmerican headache societyScientific meeting of the american headache societyHead of research development at lundbeckAmerican headacheAnnual scientific meetingScientific meetingRelations leadHeadache impactWork productivity